FDA and CDC Considering , 'Approval' of a Fourth COVID Shot , for People Over 50.
Poynter reports that United States citizens
over 50 could be approved to receive a fourth
dose of COVID vaccination as early as this week. .
The Food and Drug Administration and Centers for Disease
Control and Prevention are reportedly considering
a “permissive recommendation” for a fourth dose. .
The move would fall short of a full recommendation, instead just allowing people who wish to
receive an additional booster to get one. .
Granting a “permissive recommendation” allows
the FDA to skip the special review panels
required to grant the fourth dose full approval. .
Granting a “permissive recommendation” allows
the FDA to skip the special review panels
required to grant the fourth dose full approval. .
According to Poynter, the review panel that
determines the efficacy and safety of drugs
is not scheduled to meet until April. .
According to Poynter, the review panel that
determines the efficacy and safety of drugs
is not scheduled to meet until April. .
At that time, the panel will take up
the topic of who should be eligible
for a fourth dose in 2022. .
According to Poynter, one of the main issues
regarding boosters is a matter of timing. .
Anyone receiving a booster now runs the risk
of protection fading by the time a possible
fall/winter resurgence of COVID rolls around. .
Poynter reports that health experts consider
a surge in the fall of 2022 to be "highly likely.".
Currently, drug companies are working to create
vaccine formulas that would be effective against
different variants of the coronavirus.